American Realty Capital Properties, Inc. (NASDAQ:ARCP) has fired the next shot in the battle with RCS Capital Corp. over its termination of the Cole Capital Partners L.L.C. $700 million deal by filing a lawsuit against RCS. The lawsuit, which was filed Tuesday in the Court of Chancery in Delaware, comes about a week after RCS announced it had canceled its planned acquisition of Cole Capital Partners and Cole Capital Advisors, Inc. from an affiliate of its sister company, ARCP. American Realty Capital Properties, Inc. (NASDAQ:ARCP) belongs to Financial sector. Its net profit margin is -71.80% and weekly performance is 0.92%. On last trading day company shares ended up $8.79. American Realty Capital Properties, Inc. (NASDAQ:ARCP) distance from 50-day simple moving average (SMA50) is -23.23%. AK Steel Holding Corporation (NYSE:AKS) on Nov. 6 said the U.S. International Trade Commission (ITC) reached an affirmative (4-1) final determination that the domestic industry producing non-oriented electrical steel (NOES) is materially injured by reason of dumped and subsidized imports from six countries. AK Steel Holding Corporation (NYSE:AKS) shares decreased -1.27% in last trading session and ended the day at $6.24. AKS Gross Margin is 7.20% and its return on assets is -1.90%. AK Steel Holding Corporation (NYSE:AKS) quarterly performance is -36.00%. Vanda Pharmaceuticals Inc (NASDAQ:VNDA) this week announced the sale of 5,000,000 shares of its common stock in an underwritten public offering at a price to the public of $11.60 per share. The net offering proceeds to Vanda from the sale of the shares are expected to be approximately $54.0 million, after deducting underwriting discounts and commissions and other estimated offering expenses, but excluding any exercise of the underwriters’ option to purchase additional shares of common stock. On 12 November, Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA) shares increased 2.15% and was closed at $12.82. VNDA EPS growth in last 5 year was 19.00%. Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA) year to date (YTD) performance is 3.30%. A 4 percent increase in sales of upholstered and ready-to-assemble goods boosted Flexsteel Industries, Inc. (NASDAQ:FLXS) first quarter reportings to the company’s highest levels. Flexsteel reported net sales of $109 million, a 4 percent jump over the previous year’s reporting for the same quarter. Additionally adjusted net income for the quarter increased 14 percent to $5 million. Company officials expect to see sales numbers increase throughout the year due to an existing backlog of orders and “positive order trends,” as well as an expansion of the company’ product portfolio of upholstered goods and ready-to-assemble products. Flexsteel Industries Inc. (NASDAQ:FLXS) ended the last trading day at $35.52. Company weekly volatility is calculated as 3.89% and price to cash ratio as 25.52. Flexsteel Industries Inc. (NASDAQ:FLXS) showed a weekly performance of 5.81%. RXi Pharmaceuticals Corp (NASDAQ:RXII) last announced its earnings results on Thursday, August 14th. The company reported ($0.23) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.25) by $0.02. On average, analysts predict that RXi Pharmaceuticals Corp will post $-0.95 earnings per share for the current fiscal year. RXi Pharmaceuticals Corporation (NASDAQ:RXII) shares increased 2.72% in last trading session and ended the day at $1.89. RXII return on assets is -103.20%. RXi Pharmaceuticals Corporation (NASDAQ:RXII) quarterly performance is -31.77%.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
